Published in J Clin Oncol on October 01, 1993
Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature (2014) 2.22
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer (2004) 1.69
Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer (2004) 1.68
Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling. Science (2015) 1.59
The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer (1999) 1.46
Cancer cachexia: impact, mechanisms and emerging treatments. J Cachexia Sarcopenia Muscle (2012) 1.21
A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer. Support Care Cancer (2009) 1.15
Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer (2008) 1.08
Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. PLoS One (2014) 1.00
Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. Curr Treat Options Oncol (2010) 0.96
The nutritional risk in oncology: a study of 1,453 cancer outpatients. Support Care Cancer (2012) 0.95
The role of triglyceride lipases in cancer associated cachexia. Trends Mol Med (2013) 0.88
Nutritional therapy for cancer cachexia. Gut (2003) 0.88
Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC. Expert Opin Pharmacother (2015) 0.86
Important aspects of nutrition in children with cancer. Adv Nutr (2011) 0.86
Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study. Br J Cancer (2005) 0.85
Weight loss in cancer patients: a plea for a better awareness of the issue. Support Care Cancer (2011) 0.82
Characterization of the Yoshida sarcoma: a model of cancer cachexia. Support Care Cancer (2013) 0.82
A systematic review of health-related quality of life instruments in patients with cancer cachexia. Support Care Cancer (2013) 0.81
Treatment of non-pain-related symptoms. Cancer J (2013) 0.78
Current applications of health-related quality-of-life assessment in oncology. Support Care Cancer (1997) 0.78
Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway. Support Care Cancer (2006) 0.78
Trials in palliative care. BMJ (1995) 0.78
Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. J Cachexia Sarcopenia Muscle (2016) 0.78
Telephone-delivered nutrition and exercise counselling after auto-SCT: a pilot, randomised controlled trial. Bone Marrow Transplant (2014) 0.75
Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia. Oncogene (2016) 0.75
Chronic exendin-4 treatment prevents the development of cancer cachexia symptoms in male rats bearing the Yoshida sarcoma. Horm Cancer (2013) 0.75
Echium oil is not protective against weight loss in head and neck cancer patients undergoing curative radio(chemo)therapy: a randomised-controlled trial. BMC Complement Altern Med (2014) 0.75
The Danish National Birth Cohort--its background, structure and aim. Scand J Public Health (2001) 6.09
National character does not reflect mean personality trait levels in 49 cultures. Science (2005) 3.56
Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet (2000) 2.97
The effect of different alcohol drinking patterns in early to mid pregnancy on the child's intelligence, attention, and executive function. BJOG (2012) 2.71
The effect of alcohol binge drinking in early pregnancy on general intelligence in children. BJOG (2012) 2.20
In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA (1995) 2.15
The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on executive function in 5-year-old children. BJOG (2012) 2.14
Neonatal levels of neurotrophic factors and risk of autism spectrum disorders. Acta Psychiatr Scand (2012) 2.08
Pain in somatoform disorders: is somatoform pain disorder a valid diagnosis? Acta Psychiatr Scand (2002) 2.04
The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatr Scand (2004) 1.85
Gestational weight gain in relation to offspring body mass index and obesity from infancy through adulthood. Int J Obes (Lond) (2009) 1.72
Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatr Scand (2004) 1.59
Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients. J Natl Cancer Inst (1994) 1.59
Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke (2002) 1.50
Early identification of non-remission in first-episode psychosis in a two-year outcome study. Acta Psychiatr Scand (2010) 1.45
[Toxic epidermal necrolysis]. Ugeskr Laeger (1993) 1.39
Fertility treatment and child intelligence, attention, and executive functions in 5-year-old singletons: a cohort study. BJOG (2014) 1.38
[Treatment of primary breast cancer. Consequences of mammographic screening in the municipality of Copenhagen]. Ugeskr Laeger (1996) 1.38
Beer, wine, spirits and subjective health. J Epidemiol Community Health (1999) 1.20
The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary. Nutr Cancer (1993) 1.15
"Chronic painter's syndrome". A reanalysis of psychological test data in a group of diagnosed cases, based on comparisons with matched controls. Acta Neurol Scand (1988) 1.14
A longitudinal study of gender differences in depressive symptoms from age 50 to 80. Psychol Aging (2001) 1.12
The effects of low to moderate prenatal alcohol exposure in early pregnancy on IQ in 5-year-old children. BJOG (2012) 1.07
Pituitary adenylate cyclase-activating polypeptide-nerve terminals densely innervate corticotropin-releasing hormone-neurons in the hypothalamic paraventricular nucleus of the rat. Neurosci Lett (1998) 1.05
Mental distress in the Danish general population. Acta Psychiatr Scand (2006) 1.05
Multiple endocrine adenomatosis of mixed type. Acta Med Scand (1976) 1.02
A randomized trial assessing the impact of written information on outpatients' knowledge about and attitude toward randomized clinical trials. The INFO trial group. Control Clin Trials (2000) 1.02
The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on selective and sustained attention in 5-year-old children. BJOG (2012) 1.01
Early nasal continuous positive airway pressure in a cohort of the smallest infants in Denmark: neurodevelopmental outcome at five years of age. Acta Paediatr (2004) 1.00
Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves. J Cereb Blood Flow Metab (2000) 0.99
Pituitary adenylate cyclase activating polypeptide immunoreactivity in capsaicin-sensitive nerve fibres supplying the rat urinary tract. Neuroscience (1998) 0.97
Prognosis of myelomatosis on treatment with prednisone and cytostatics. Scand J Haematol (1973) 0.96
Expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the postnatal and adult rat cerebellar cortex. Neuroreport (1998) 0.96
Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol (2010) 0.96
Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study. Cancer Chemother Pharmacol (2000) 0.95
Pituitary adenylyl cyclase-activating peptide: a pivotal modulator of glutamatergic regulation of the suprachiasmatic circadian clock. Proc Natl Acad Sci U S A (1999) 0.94
Pituitary adenylate cyclase activating peptide expression in the rat dorsal root ganglia: up-regulation after peripheral nerve injury. Neuroscience (1996) 0.94
Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence. Brain Res (1995) 0.92
Neuroglobin expression in the rat suprachiasmatic nucleus: colocalization, innervation, and response to light. J Comp Neurol (2010) 0.91
Cognitive function in adult offspring of women with Type 1 diabetes. Diabet Med (2011) 0.91
PACAP in the adrenal gland--relationship with choline acetyltransferase, enkephalin and chromaffin cells and effects of immunological sympathectomy. Neuroreport (1996) 0.90
Pituitary adenylate cyclase-activating peptide in sensory and autonomic ganglia: localization and regulation. Ann N Y Acad Sci (1996) 0.89
Effects of breast-feeding on cognitive function. Adv Exp Med Biol (2009) 0.89
Innervation pattern and Ca2+ signalling in labial salivary glands of healthy individuals and patients with primary Sjögren's syndrome (pSS). J Oral Pathol Med (2000) 0.87
Diurnal rhythmicity of the canonical clock genes Per1, Per2 and Bmal1 in the rat adrenal gland is unaltered after hypophysectomy. J Neuroendocrinol (2008) 0.87
Neuronal localization of pituitary adenylate cyclase-activating polypeptide 38 in the adrenal medulla and growth-inhibitory effect on chromaffin cells. Neuroscience (1995) 0.87
Active life in old age. Combining measures of functional ability and social participation. Dan Med Bull (1999) 0.86
Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B. Glycobiology (1997) 0.86
Breastfeeding and risk of schizophrenia in the Copenhagen Perinatal Cohort. Acta Psychiatr Scand (2005) 0.86
Genetic priming of a proinflammatory profile predicts low IQ in octogenarians. Neurobiol Aging (2007) 0.85
Electrical taste detection thresholds and chemical smell detection thresholds in patients with cancer. Cancer (1991) 0.84
Light-induced phase shift in the Syrian hamster (Mesocricetus auratus) is attenuated by the PACAP receptor antagonist PACAP6-38 or PACAP immunoneutralization. Eur J Neurosci (2003) 0.84
Pituitary adenylate cyclase-activating peptide (PACAP) and PACAP type 1 receptor expression in regenerating adult mouse and rat superior cervical ganglia in vitro. Brain Res (1997) 0.84
Increased expression, axonal transport and release of pituitary adenylate cyclase-activating polypeptide in the cultured rat vagus nerve. Neuroscience (1999) 0.84
Pituitary adenylate cyclase activating peptide-38 (PACAP-38), PACAP-27, and PACAP related peptide (PRP) in the rat median eminence and pituitary. J Neuroendocrinol (1995) 0.83
PACAP-(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38). Am J Physiol (1997) 0.83
The Prenatal Development Project. Acta Psychiatr Scand Suppl (1993) 0.83
Association between pituitary adenylate cyclase-activating polypeptide and thyrotropin-releasing hormone in the rat hypothalamus. J Chem Neuroanat (1997) 0.83
The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities. Acta Neurol Scand (2007) 0.82
Induction of pituitary adenylate cyclase-activating polypeptide mRNA in the medial parvocellular part of the paraventricular nucleus of rats following kainic-acid-induced seizure. Neuroendocrinology (2000) 0.82
Evans' syndrome in IgA deficiency. Episodic autoimmune haemolytic anaemia and thrombocytopenia during a 10 years observation period. Scand J Haematol (1982) 0.82
Classification and prognostic variables in myelomatosis. Scand J Haematol (1985) 0.81
High-dose platinum consisting of combined carboplatin and cisplatin in previously untreated ovarian cancer patients with residual disease. J Clin Oncol (1989) 0.81
Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter. Br J Pharmacol (1995) 0.81
PreproPACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP. Regul Pept (1995) 0.81
Immunocytochemical demonstration of pituitary adenylate cyclase activating polypeptide (PACAP) in the porcine epiphyseal cartilage canals. Neuropeptides (1997) 0.80
Pituitary adenylate cyclase-activating polypeptide induces period1 and period2 gene expression in the rat suprachiasmatic nucleus during late night. Neuroscience (2001) 0.80
Serum erythropoietin in myelomatosis. Scand J Haematol (1977) 0.80
Embryonic expression of pituitary adenylate cyclase-activating polypeptide in sensory and autonomic ganglia and in spinal cord of the rat. J Comp Neurol (1998) 0.80
Nitric oxide synthase-containing, peptide-containing, and acetylcholinesterase-positive nerves in the cat lower oesophagus. Histochem J (1994) 0.80
Restricted expression of Neuroglobin in the mouse retina and co-localization with Melanopsin and Tyrosine Hydroxylase. Biochem Biophys Res Commun (2012) 0.80
Pituitary adenylate cyclase-activating polypeptide: occurrence and relaxant effect in female genital tract. Am J Physiol (1995) 0.80
Height, weight and body mass index in early adulthood and risk of schizophrenia. Acta Psychiatr Scand (2006) 0.80
Intravenous radionuclide angioscintigraphy and computer tomography in cerebral arteriovenous malformations. Acta Neurol Scand Suppl (1983) 0.80
PACAP-(1-38) as neurotransmitter in the porcine adrenal glands. Am J Physiol Endocrinol Metab (2000) 0.80
Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum. Br J Pharmacol (1995) 0.79
Pituitary adenylate cyclase-activating polypeptide is an auto/paracrine stimulator of acute progesterone accumulation and subsequent luteinization in cultured periovulatory granulosa/lutein cells. Endocrinology (1999) 0.79
PACAP in visceral afferent nerves supplying the rat digestive and urinary tracts. Ann N Y Acad Sci (1998) 0.79
Transient periovulatory expression of pituitary adenylate cyclase activating peptide in rat ovarian cells. Endocrinology (1996) 0.79
Interrelationships between blood volume, venous haematocrit and renal failure in myelomatosis. Scand J Haematol (1978) 0.79
Simultaneous quantification of red cell and platelet surface-bound IgG & IgM by an ELISA technique. Scand J Clin Lab Invest Suppl (1984) 0.79
PACAP and PACAP receptors in insulin producing tissues: localization and effects. Regul Pept (1998) 0.79
Red blood cell membrane-bound IgG: demonstration of antibodies in patients with autoimmune haemolytic anaemia and immune complexes in patients with rheumatic diseases. Clin Lab Haematol (1984) 0.78
Bone marrow studies in myelomatosis. Scand J Haematol (1978) 0.78
Taste thresholds in patients with small-cell lung cancer. J Cancer Res Clin Oncol (1991) 0.78
Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapy. Ann Oncol (1992) 0.78
Coping strategies among the long-term mentally ill: categorization and clinical determinants. Acta Psychiatr Scand (1997) 0.78
Temporal gradient in the remote memory impairment of amnesic patients with lesions in the basal forebrain. Neuropsychologia (1990) 0.78
Increased myelosuppression during cytostatic treatment and pleural effusion in patients with small cell lung cancer. Eur J Cancer (1992) 0.78
The Category Cued Recall test in very mild Alzheimer's disease: discriminative validity and correlation with semantic memory functions. Eur J Neurol (2007) 0.78
Discrimination between organic and hepatic encephalopathy by means of continuous reaction times. Liver (1985) 0.78
Personality traits in unaffected twins discordant for affective disorder. Acta Psychiatr Scand (2007) 0.78
Pituitary adenylate cyclase activating peptide (PACAP) mRNA in the rat neocortex. Neurosci Lett (1994) 0.78
Quantitation of erythropoiesis in myelomatosis. Scand J Haematol (1979) 0.78
Phase II study of gemcitabine in previously platinum-treated ovarian cancer patients. Anticancer Drugs (1995) 0.78
Primary hemangiosarcoma of the spleen with angioscintigraphic demonstration of metastases. Cancer (1984) 0.78